Cryomass Technologies (Cryomass Technologies) 5-Year EBITDA Growth Rate : -116.60% (As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Cryomass Technologies 5-Year EBITDA Growth Rate?

Cryomass Technologies's EBITDA per Share for the three months ended in Sep. 2023 was $-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was -10.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -116.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cryomass Technologies was -10.60% per year. The lowest was -304.10% per year. And the median was -174.30% per year.

Competitive Comparison of Cryomass Technologies's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Cryomass Technologies's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryomass Technologies's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cryomass Technologies's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cryomass Technologies's 5-Year EBITDA Growth Rate falls into.

Cryomass Technologies 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Cryomass Technologies (OTCPK:CRYM) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Cryomass Technologies 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cryomass Technologies's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryomass Technologies (Cryomass Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cryomass Technologies Inc (OTCPK:CRYM) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1001 Bannock Street, Suite 612, Denver, CO, USA, 80204

Website

https://www.cryomass.com

Cryomass Technologies Inc designs, manufactures, and licenses field-mobile equipment for the handling of harvested cannabis, hemp, and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect and protect the high-value compounds from the harvested plant. The company's offerings include refinement systems and monitoring and control systems.

Executives

Philip Blair Mullin	officer: Chief Financial Officer	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Christian Noel	director, officer: Chief Executive Officer	3531 SOUTH LOGAN ST. SUITE D-357, ENGLEWOOD CO 80113
Patricia Izabel Kovacevic	officer: GC, Corp Secy, and Head of EA	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Delon Hannes Human	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mark Radke	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mario Gobbo	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113